At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Adaptyv is building an automated lab thats let AI agents run biology experiments. Were entering the era of agentic science where AI models can now design novel proteins, propose hypotheses, and iterate on experimental results. But
The purpose of Idorsia is to challenge accepted medical paradigms, answering the questions that matter most. To achieve this, we will discover, develop, and commercialize transformative medicines – either with in-house capabilities or together with partners
The Bachem Group is investing in a new planned site in Sisslerfeld in Northwestern Switzerland. This step is part of the long-term strategy to expand production capacity by the end of the decade. The new production
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
About This Role The PO&T Commercial Asset Development Leader is a member of the Asset Development & Portfolio Management (ADPM) team which provides cross-functional guidance across PO&T’s line functions for commercial assets. The role oversees and
About This Role: The Global Launch and Commercial Operations Lead is a senior individual contributor accountable for the end‑to‑end governance, readiness, and execution excellence of Biogen’s global commercial launch of zorevunersen — a potential first-in-class disease-modifying
Salary Range:CHF122,500.00 - CHF227,500.00 BandLevel 5 Job Description Summary#LI-Hybrid Location: Basel, Switzerland As a Translational Medicine Expert (TME) you will provide medical and scientific expertise and leadership to: •Drive success of early global programs, develop and
At Capgemini Invent, we believe difference drives change. As inventive transformation consultants, we blend our strategic, creative and scientific capabilities,collaborating closely with clients to deliver cutting-edge solutions. Join us to drive transformation tailored to our clients
Choosing Capgemini means choosing a company where you will be empowered to shape your career in the way you’d like, where you’ll be supported and inspired bya collaborative community of colleagues around the world, and where
Salary Range:CHF122,500.00 - CHF227,500.00 BandLevel 5 Job Description Summary#LI-Hybrid Location: Basel, Switzerland Internal Title: Strategic Feasibility Expert (SFE) This role is based in Basel, Switzerland. Novartis is unable to offer relocation support for this role: please
About the Company The purpose of Idorsia is to discover, develop, and commercialize innovative medicines to help more patients. Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Shape the future of bioanalysis for innovative medicines Celerion is a leading global contract research organization (CRO) specializing in early clinical research and bioanalytical services. For more than 40 years, we have partnered with pharmaceutical and
Salary Range:CHF93,800.00 - CHF174,200.00 Job Description SummaryLocation: Basel - Onsite #LI-Onsite Novartis cannot offer relocation for this role, please apply if this location is accessible to you. About Us: Novartis Biomedical Research (BR) is the innovation